Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug-resistant organisms in a Dutch

Quinten R Ducarmon1,2, Elisabeth M Terveer3,4, Sam Nooij3,4

  • 1Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands. q.r.ducarmon@lumc.nl.

Genome Medicine
|April 8, 2021
PubMed
Abstract

Insights

Nursing home residents frequently carry multidrug-resistant organisms (MDROs). Specific gut bacteria like Dorea may protect against MDROs, while high Bifidobacterium abundance was noted in this population.

Area of Science:

  • Microbiology
  • Gerontology
  • Infectious Diseases

Background:

  • Nursing home residents exhibit higher rates of intestinal colonization with multidrug-resistant organisms (MDROs).
  • Understanding MDRO colonization, spread, and risk factors in this vulnerable population is crucial.
  • Investigating the gut microbiota's role in colonization resistance against MDROs is essential.

Purpose of the Study:

  • To assess MDRO colonization and spread in nursing home residents.
  • To identify clinical risk factors associated with MDRO colonization.
  • To explore the gut microbiota's influence on colonization resistance against MDROs.

Main Methods:

  • A prospective cohort study was conducted in a Dutch nursing home over six months.
  • Demographical, clinical, and epidemiological data were collected from 27 residents across four time points.
  • Faecal samples were analyzed using 16S rRNA gene amplicon sequencing and whole-genome sequencing.

Main Results:

  • 29% of analyzed samples were MDRO-positive, with 44.4% of residents colonized at some point.
  • Antibiotic use and prior hospital admittance were linked to MDRO colonization.
  • Specific bacterial taxa (Dorea, Atopobiaceae, Lachnospiraceae ND3007 group) were more abundant in non-colonized residents.

Conclusions:

  • The gut microbiota plays a role in colonization resistance against MDROs in elderly nursing home residents.
  • Dorea, Atopobiaceae, and Lachnospiraceae ND3007 group may confer protection against MDRO colonization.
  • A high abundance of Bifidobacterium species was observed, potentially contributing to colonization resistance.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...